Enantioselectivity of structurally modified poly(sodium undecenoyl-L-leucinate) by insertionof Triton X-102 surfactant molecules
Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors
§ 102
Case 102
102 a. Beilage zum Brief Nr. 102
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Quantitative proteomic analysis of the inhibitory effects of CIL-102 on viability and invasiveness in human glioma cells
CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability
§. 102